These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 10763203)

  • 1. [Aspirin and prevention of cardiovascular risk].
    Karila-Cohen D; Gabriel Steg P
    Rev Med Interne; 2000 Mar; 21 Suppl 1():35s-40s. PubMed ID: 10763203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet therapy--Part I.
    Goodnight SH; Coull BM; McAnulty JH; Taylor LM
    West J Med; 1993 Apr; 158(4):385-92. PubMed ID: 8317125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet drugs in cardiovascular prevention: coronary events: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):83-5. PubMed ID: 11010749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and its rivals. As your options increase, your choices get harder.
    Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
    [No Abstract]   [Full Text] [Related]  

  • 5. COX-2 selective NSAIDs.
    Ryan NS
    Cleve Clin J Med; 2000 Jan; 67(1):67. PubMed ID: 10645679
    [No Abstract]   [Full Text] [Related]  

  • 6. New antiplatelet agents.
    White HD; French JK; Ellis CJ
    Aust N Z J Med; 1998 Aug; 28(4):558-64. PubMed ID: 9777140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) pilot study.
    Altman R; Luciardi HL; Muntaner J; Del Rio F; Berman SG; Lopez R; Gonzalez C
    Circulation; 2002 Jul; 106(2):191-5. PubMed ID: 12105157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulation and antiaggregation in cardiac patients].
    Meyer BJ
    Ther Umsch; 2003 Jan; 60(1):27-32. PubMed ID: 12638475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet therapy in acute coronary syndrome and atrial fibrillation: aspirin.
    Tanguay JF
    Adv Cardiol; 2012; 47():20-30. PubMed ID: 22906900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aspirin. A wonder drug?].
    Diez-Ewald M
    Invest Clin; 1997 Jun; 38(2):59-61. PubMed ID: 9296640
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis.
    Circulation; 1997 Sep; 96(5):1445-53. PubMed ID: 9315530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspirin and cerebral ischemic accidents].
    Crassard I; Niclot P; Bousser MG
    Rev Med Interne; 2000 Mar; 21 Suppl 1():41s-49s. PubMed ID: 10763204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic, antithrombin, and antiplatelet treatment of acute coronary syndromes.
    Puma JA; Sketch MH
    J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S8-12. PubMed ID: 11191119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redefining the Roles of Aspirin across the Spectrum of Cardiovascular Disease Prevention.
    Brown MT; Bortfeld KS; Sperling LS; Wenger NK
    Curr Cardiol Rev; 2023; 19(6):9-22. PubMed ID: 37132104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
    Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
    N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present treatment options for unstable angina and non-Q-wave myocardial infarction.
    Lairikyengbam SK; Davies AG; Anderson MH
    QJM; 2001 Jan; 94(1):5-11. PubMed ID: 11161130
    [No Abstract]   [Full Text] [Related]  

  • 19. Appropriate antiplatelet and antithrombotic therapy in patients with acute coronary syndromes: recent updates to the ACC/AHA guidelines.
    Mehta SR;
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():27E-34E; quiz 35E. PubMed ID: 12668860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability in response to aspirin: do we understand the clinical relevance?
    Campbell CL; Steinhubl SR
    J Thromb Haemost; 2005 Apr; 3(4):665-9. PubMed ID: 15703034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.